Teva Pharmaceutical Industries Limited (NYSE:TEVA) down to US$10b market cap, but institutional owners may not be as affected after a year of 7.9% returns - Simply Wall St News
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
TEVA Stock Price and Chart — TASE:TEVA — TradingView
Chief Accounting Officer Amir Weiss Sells 31,766 Shares of Teva Pharmaceutical Industries Ltd
Teva Stock Is Still Cheap; Q4 Earnings Should Show Turnaround Progress | investing.com
TEVA -- Is Its Stock Price A Worthy Investment? Learn More.